GOLDSTEIN MICHAEL 4
4 · Teladoc Health, Inc. · Filed Apr 17, 2020
Insider Transaction Report
Form 4
GOLDSTEIN MICHAEL
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2020-04-16−1,700→ 8,000 totalExercise: $16.64Exp: 2026-08-08→ Common Stock (1,700 underlying) - Sale
Common Stock
2020-04-16$165.93/sh−918$152,324→ 14,805 total - Exercise/Conversion
Common Stock
2020-04-16$8.71/sh+13,105$114,145→ 14,023 total - Exercise/Conversion
Common Stock
2020-04-16$16.64/sh+1,700$28,288→ 15,723 total - Exercise/Conversion
Stock Option (right to buy)
2020-04-16−13,105→ 0 totalExercise: $8.71Exp: 2025-02-25→ Common Stock (13,105 underlying) - Sale
Common Stock
2020-04-16$169.13/sh−14,805$2,503,970→ 0 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 29, 2020.
- [F2]Represents the weighted average price of transactions ranging from $166.00 to $171.06. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The option vested as to 25% of the shares on February 25, 2016. The remainder of the shares vested in 36 equal monthly installments thereafter.
- [F4]The option vested in full on May 24, 2017.